Stay updated on DONATE Study: Dapagliflozin Safety in T2DM Clinical Trial
Sign up to get notified when there's something new on the DONATE Study: Dapagliflozin Safety in T2DM Clinical Trial page.

Latest updates to the DONATE Study: Dapagliflozin Safety in T2DM Clinical Trial page
- ChecktodayChange DetectedThe page no longer displays the primary condition 'Type 2 diabetes' and the 'related topics' section including 'MedlinePlus Genetics', reducing explicit disease context and linked resources for the study.SummaryDifference0.1%

- Check7 days agoChange DetectedAdded 'Type 2 diabetes' as a topic tag. Introduced a related topics entry featuring MedlinePlus Genetics to connect the study to genetics resources.SummaryDifference0.1%

- Check14 days agoChange DetectedNew page revision tag added: Revision: v3.6.6. The 'Type 2 diabetes' descriptor and the related topic 'MedlinePlus Genetics' are removed from the page, changing how the study's condition and topics are presented.SummaryDifference0.1%

- Check21 days agoNo Change Detected
- Check35 days agoChange DetectedAdded the Type 2 diabetes topic and a related topics entry linking to MedlinePlus Genetics. Updated the revision tag from v3.6.4 to v3.6.5.SummaryDifference0.1%

- Check42 days agoChange DetectedThe MedlinePlus related topics section no longer lists 'Diabetes Type 2' and 'MedlinePlus Genetics', removing these consumer health resource links from the page.SummaryDifference0.1%

- Check50 days agoChange DetectedThe page's revision was updated from v3.6.3 to v3.6.4, indicating a small internal build update to the page; no study content or data were changed.SummaryDifference0.0%

Stay in the know with updates to DONATE Study: Dapagliflozin Safety in T2DM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the DONATE Study: Dapagliflozin Safety in T2DM Clinical Trial page.